Lon Cardon - Dec 19, 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Jody Howe, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Dec 19, 2022
Transactions value $
$0
Form type
4
Date filed
12/19/2022, 08:26 PM
Next filing
Jun 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Award $0 +34K $0.00 34K Dec 19, 2022 Common Stock 34K $18.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant (December 19, 2022).